sulbactam has been researched along with Heart Valve Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Le Conte, P; Le Floch, R; Le Gallou, F; Potel, G; Xiong, YQ; Zhou, XY | 1 |
1 other study(ies) available for sulbactam and Heart Valve Diseases
Article | Year |
---|---|
Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both.
Topics: Amikacin; Animals; Aortic Valve; beta-Lactamases; Ceftazidime; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis; Female; Heart Valve Diseases; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sulbactam | 1995 |